Key activities | Determinants | Screening strategy 1.2 | Risk-based strategy1,2 | Combination strategy1,2 | Dutch guideline 1,2 |
---|---|---|---|---|---|
Identifying risk factors | Procedural clarity (guideline) | 3 | 3 | 3 | 3 |
Unclear definition previous child with EOGBS | N | N | N | N | |
No standard cut-off point urinary tract infection despite guideline | N | N | N | N | |
No standard procedure PROM (referral after 18, 24, > 24 hours) | N | N | N | N | |
Correctness (guideline) | 1 | 1 | 1 | 1 | |
Symptoms of urinary tract infection are often missed | N | N | N | N | |
Social support by other care providers (user) | 2 | 2 | 2 | 2 | |
No adequate history taking of previous child with EOGBS | N | N | N | N | |
Not standard GBS detection in urine culture by general practitioner, therefore AB treatment not directed at GBS because status unknown | N | N | N | N | |
Legislation and regulations (socio-political context) | 1 | 1 | 1 | 1 | |
Data exchange between care providers of previous pregnancy | N | N | N | N | |
Screening for GBS colonization (swab taking) | Procedural clarity (guideline) | 1 | 0 | 1 | 1 |
Local differences in swab taking (vaginal /vs vaginal rectal /vs urine) | N | N | N | ||
Correctness (guideline) | 0 | 0 | 0 | 1 | |
Test result swab taken during birth not available in time | N | ||||
Compatibility with current guideline (guideline) | 1 | 0 | 1 | 0 | |
Collaboration with laboratory already in place | P | P | |||
Personal benefits / drawbacks (user) | 1 | 0 | 1 | 0 | |
Extra work for primary care midwives | N | N | |||
Outcome expectations (user) | 4 | 0 | 4 | 0 | |
Sensitivity/specificity swab not 100% because of intermittent carrier status | N | N | |||
Women can adequately take swab themselves (validity culture) | N/P | N/P | |||
Swab result not available for every woman at time of birth | N | N | |||
Client/patient satisfaction (user) | 3 | 0 | 3 | 0 | |
Women do not like swab taking | N | N | |||
Women prefer swab taking for reassurance | P | P | |||
Increases anxiety in women and partners | N | N | |||
Social support by other care provider (user) | 2 | 0 | 2 | 0 | |
Data exchange culture results | N/P | N/P | |||
Self-efficacy (user) | 1 | 0 | 1 | 0 | |
Confidence in discussing test results with women | P | P | |||
Knowledge (user) | 1 | 0 | 1 | 0 | |
Care providers know how to take a swab | P | P | |||
Time available (organisational context) | 1 | 0 | 1 | 0 | |
Time consuming because of providing information and swab taking | N | N | |||
Staff capacity (organisational context) | 1 | 0 | 1 | 0 | |
Sufficient capacity laboratory personnel | P | P | |||
Material resources and facilities (organisational context) | 3 | 0 | 3 | 0 | |
Easy to administer in primary care | P | P | |||
Swabs not available | N | N | |||
Often delay if culture taken in primary care | N | N | |||
Financial resources (organisational context) | 2 | 0 | 2 | 0 | |
Increased costs in primary care (swab taking) | N | N | |||
Increased costs in laboratory personnel | N | N | |||
Total numbers of determinants, related to | 28 | 7 | 28 | 9 | |
the guideline itself | 6 | 4 | 6 | 6 | |
the user (care provider) | 14 | 2 | 14 | 2 | |
the organisational context | 7 | 0 | 7 | 0 | |
the socio-political context | 1 | 1 | 1 | 1 |